tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA
Canadian Market

Medicenna Therapeutics Corp (MDNA) Financial Statements

Compare
229 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently C$64.60M. The company's EPS TTM is C$-0.06; its P/E ratio is -5.48; Medicenna Therapeutics Corp is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00KC$ -40.00K
Operating IncomeC$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30MC$ -17.19M
EBITDAC$ -12.97MC$ -18.67MC$ -16.30MC$ -22.54MC$ -17.25M
Net IncomeC$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65MC$ -17.18M
Balance Sheet
Cash & Short-Term InvestmentsC$ 24.84MC$ 16.98MC$ 33.60MC$ 20.54MC$ 40.38M
Total AssetsC$ 28.38MC$ 19.13MC$ 36.45MC$ 23.46MC$ 42.25M
Total DebtC$ 168.00KC$ 0.00C$ 0.00C$ 0.00C$ 34.00K
Net DebtC$ -24.67MC$ -16.98MC$ -33.60MC$ -20.54MC$ -30.34M
Total LiabilitiesC$ 9.29MC$ 13.94MC$ 6.96MC$ 2.62MC$ 4.11M
Stockholders' EquityC$ 19.09MC$ 5.19MC$ 29.49MC$ 20.84MC$ 38.15M
Cash Flow
Free Cash FlowC$ -16.52MC$ -16.26MC$ -12.66MC$ -23.58MC$ -15.31M
Operating Cash FlowC$ -16.49MC$ -16.26MC$ -12.66MC$ -23.58MC$ -15.31M
Investing Cash FlowC$ -33.00KC$ 0.00C$ -13.05MC$ 10.05MC$ 5.01M
Financing Cash FlowC$ 23.49MC$ 0.00C$ 24.76MC$ 3.88MC$ 18.26M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Medicenna Therapeutics Corp Debt to Assets

Medicenna Therapeutics Corp Cash Flow

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS